News

MPR
empr.com > news > mixed-results-seen-in-risk-analysis-of-selective-serotonin-reuptake-inhibitor-use-during-pregnancy

Mixed Results Seen in Risk Analysis of Selective Serotonin Reuptake Inhibitor Use During Pregnancy

9+ hour, 20+ min ago  (177+ words) Higher risk for gestational diabetes and some poor newborn outcomes reported, but lower risk for some adverse pregnancy outcomes also found. HealthDay News " Use of selective serotonin reuptake inhibitor (SSRI) medication during pregnancy may increase the risk for gestational diabetes…...

MPR
empr.com > news > synthetic-psilocybin-improves-symptom-severity-in-treatment-resistant-depression

Synthetic Psilocybin Improves Symptom Severity in Treatment-Resistant Depression

2+ day, 10+ hour ago  (272+ words) Topline data were announced from a phase 3 study evaluating COMP360, a synthetic, proprietary formulation of psilocybin, in patients with treatment-resistant depression (TRD). Study participants (N=581) were randomly assigned 2:1:1 to receive 2 administrations of COMP360 psilocybin in doses of 25mg (n=296), 10mg (n=142) or 1mg (n=143), taken…...

MPR
empr.com > news > smfm-mental-health-emergency-rate-elevated-with-discontinuation-of-antidepressants-in-pregnancy

SMFM: Mental Health Emergency Rate Elevated With Discontinuation of Antidepressants in Pregnancy

6+ day, 15+ hour ago  (272+ words) HealthDay News " Pregnant patients who discontinue their antidepressant medication during pregnancy are more likely to experience a mental health emergency, according to a study presented at The ... HealthDay News " Pregnant patients who discontinue their antidepressant medication during pregnancy are more…...

MPR
empr.com > news > lasting-benefit-seen-for-vagus-nerve-stimulation-in-treatment-resistant-depression

Lasting Benefit Seen for Vagus Nerve Stimulation in Treatment-Resistant Depression

4+ week, 6+ hour ago  (281+ words) More than 80% of patients with clinically meaningful benefit at 12 months maintain that benefit at 18 and 24 months. HealthDay News " Among patients with treatment-resistant major depressive disorder ... HealthDay News " Among patients with treatment-resistant major depressive disorder (MDD), most of those who achieve benefit…...

MPR
empr.com > news > prescription-digital-therapeutic-lumosityrx-cleared-for-adult-adhd

Prescription Digital Therapeutic LumosityRx Cleared for Adult ADHD

2+ mon, 1+ week ago  (249+ words) The Food and Drug Administration (FDA) has cleared Lumos Labs" prescription digital therapeutic, LumosityRx, to improve attention function in adults aged 22 to 55 years with primarily inattentive or combined-type attention deficit hyperactivity disorder (ADHD). LumosityRx is a prescription therapeutic app that…...

MPR
empr.com > news > mental-health-substance-use-visits-common-among-physicians

Mental Health, Substance Use Visits Common Among Physicians

2+ mon, 4+ week ago  (284+ words) Proportion of physicians with MHSU care stable prepandemic, then increased, with larger increases seen during first two years of pandemic. HealthDay News " Mental health and substance use (MHSU) visits are common among physicians and increased substantially during the first 2 years…...

MPR
empr.com > news > low-dose-ketamine-aids-chronic-refractory-pain

Low-Dose Ketamine Aids Chronic Refractory Pain

3+ mon, 4+ week ago  (493+ words) HealthDay News " Low-dose ketamine for chronic refractory pain shows therapeutic benefit and high tolerability, according to a study published online October 5 in Regional Anesthesia & Pain Medicine....

MPR
empr.com > news > fda-denies-approval-of-brexpiprazole-plus-sertraline-for-ptsd

FDA Denies Approval of Brexpiprazole Plus Sertraline for PTSD

4+ mon, 2+ week ago  (241+ words) The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Otsuka and Lundbeck regarding the supplemental New Drug Application (sNDA) for brexpiprazole in combination with sertraline for the treatment of adults with posttraumatic stress disorder (PTSD)....

MPR
empr.com > news > adjunctive-ketogenic-diet-beneficial-for-major-depressive-disorder

Adjunctive Ketogenic Diet Beneficial for Major Depressive Disorder

5+ mon, 4+ day ago  (591+ words) A ketogenic diet (KD) is a feasible adjunctive therapy and is associated with improvements in depression symptoms among young adults with major depressive disorder (MDD), according to a study ... HealthDay News " A ketogenic diet (KD) is a feasible adjunctive therapy and…...

MPR
empr.com > news > single-psychedelic-dose-reduces-symptoms-of-generalized-anxiety-disorder

Single Psychedelic Dose Reduces Symptoms of Generalized Anxiety Disorder

5+ mon, 1+ week ago  (416+ words) However, the 25-g and 50-g dose groups did not reach significant differences vs placebo. HealthDay News " A single dose of a pharmaceutical formulation of LSD provides significant relief for ......